Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Regennova
AddedFeb 17, 2024
UpdatedJun 18, 2026
Regennova

Regennova

Angel

Regennova: A biotech firm innovating medical solutions for neurological disorders and inflammatory illnesses.

HQ
Durham, NC, US
Founded
2022
Overview
Compare
Fundraising
Employees
Website

Regennova, founded with a mission to combat life-threatening disorders, is a biotech firm dedicated to developing innovative medical solutions for inflammatory illnesses and neurological disorders such as Cerebral Stroke, Traumatic Brain Injury, and Alzheimer's disease. The company focuses on restoring immune balance to tackle infections and injuries, aiming to improve patient outcomes through cutting-edge research and development.

Notable figures affiliated with Regennova include leading scientists and medical professionals specializing in neurology and immunology. The company has secured investments from prominent venture capital firms in the biotech sector. Key achievements include successful preclinical trials demonstrating the efficacy of their treatments. Regennova's impact lies in its potential to revolutionize the treatment landscape for debilitating neurological conditions, offering hope to millions of patients worldwide.

Regennova - Similar Companies

Novoron Bioscience logo

Novoron Bioscience

novoron.com

Ventrinova logo

Ventrinova

BioRegenx logo

BioRegenx

bioregenx.com

Rejuvitas logo

Rejuvitas

rejuvitas.com

Convalesce logo

Convalesce

convalesce.co

Renerva logo

Renerva

renerva.com

Endogena Therapeutics logo

Endogena Therapeutics

Revive Biotechnology logo

Revive Biotechnology

revivebiotech.com

Revagenix logo

Revagenix

revagenix.com

ReNetX Bio logo

ReNetX Bio

renetx.com

Reservoir Neuroscience logo

Reservoir Neuroscience

reservoirneuro.com

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Neuraly logo

Neuraly

neuralymed.com

RegenX logo

RegenX

Regenemed logo

Regenemed

regenemed.com

Regennova - Quick Facts

Who are Regennova's competitors?

Companies similar to Regennova include Novoron Bioscience, Ventrinova, BioRegenx and Rejuvitas.

When was Regennova founded?

Regennova was founded in 2022.

Where is Regennova's headquarters located?

Regennova's headquarters is located in Durham, NC, US.

When was Regennova's last funding round?

Regennova's most recent funding round was for $5k (USD) in August 2022.

How much has Regennova raised to-date?

As of Aug 10, 2022, Regennova has raised a total of $5k (USD).

How many employees does Regennova have?

Regennova has 5 employees as of Feb 4, 2024.

Regennova - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Medical Solutions
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified